1 Result(s)
within
Nikeshan Jeyakumar
Medicine & Public Health
Cancer Research
Intensive / Critical Care Medicine
Medicine/Public Health, general
-
Article
CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results
Chimeric antigen receptor (CAR) T cells targeting CD22 (CD22-CAR) provide a therapeutic option for patients with CD22+ malignancies with progression after CD19-directed therapies. Using on-site, automated, closed...
